Cancer Risk in ATM Heterozygotes: A Model of Phenotypic and Mechanistic Differences between Missense and Truncating Mutations

Gatti, 1998, Ataxia–telangiectasia, 275

Swift, 1991, Incidence of cancer in 161 families affected by ataxia-telangiectasia, New Engl J Med, 325, 1831, 10.1056/NEJM199112263252602

Athma, 1996, Molecular genotyping shows that ataxia–telangiectasia heterozygotes are predisposed to breast cancer, Cancer Genet Cytogenet, 92, 130, 10.1016/S0165-4608(96)00328-7

Lange, 1995, Localization of an ataxia-telangiectasia gene to a ∼500 kb interval on chromosome 11q23, Am J Hum Genet, 57, 119

Savitsky, 1995, A single ataxia-telangiectasia gene with a product similar to PI-3 kinase, Science, 268, 1749, 10.1126/science.7792600

Vorechovsky, 1996, The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation, Cancer Res, 56, 2726

Vorechovsky, 1996, ATM mutations in cancer families, Cancer Res, 56, 4130

FitzGerald, 1997, Heterozygous ATM mutations do not contribute to early onset of breast cancer, Nature Genet, 15, 307, 10.1038/ng0397-307

Bay, 1998, No evidence for constitutional ATM mutation in breast/gastric cancer families, Int J Oncol, 12, 1385

Chen, 1998, The role of ataxia–telangiectasia heterozygotes in familial breast cancer, Cancer Res, 58, 1376

Shafman, T, D, Levitz, S, Nixon, A, J, Gibans, L-A, Nichols, K, E, Bell, D, W, Ishioka, C, Isselbacher, K, J, Gelman, R, Garber, J, Harris, J, R, Haber, D, A, Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor, Genes, Chromosomes Cancer, in press.

Bishop, 1997, AT-tributable risks, Nature Genet, 15, 226, 10.1038/ng0397-226

Gilad, 1996, Predominance of null mutation in ataxia-telangiectasia, Hum Mol Genet, 5, 433, 10.1093/hmg/5.4.433

Telatar, 1996, Ataxia-telangiectasia: Mutations in ATM cDNA detected by protein-truncation screening, Am J Hum Genet, 59, 40

Telatar, 1998, A model for ATM heterozygote identification in a large population: Four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia, Mol Genet Metabol, 64, 36, 10.1006/mgme.1998.2693

Stankovic, 1998, ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer, Am J Hum Genet, 62, 334, 10.1086/301706

Concannon, 1997, Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia, Hum Mutat, 10, 100, 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O

Stilgenbauer, 1997, Evidence for ATM as a tumor suppressor gene in T-prolymphocytic leukemia, Nature Med, 3, 1155, 10.1038/nm1097-1155

Yuille, 1998, ATM is usually rearranged in T-cell prolymphocytic leukemia, Oncogene, 16, 789, 10.1038/sj.onc.1201603

Bullrich, 1999, ATM mutations in B-cell chronic lymphocytic leukemia, Cancer Res, 59, 24

Stankovic, 1999, Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia, Lancet, 353, 26, 10.1016/S0140-6736(98)10117-4

Vorechovsky, 1997, Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia, Nature Genet, 17, 96, 10.1038/ng0997-96

Swift, 1986, The incidence and gene frequency of ataxia-telangiectasia in the United States, Am J Hum Genet, 39, 573

Banin, 1998, Enhanced phosphorylation of p53 by ATM in response to DNA damage, Science, 281, 1674, 10.1126/science.281.5383.1674

Wright, 1996, A high frequency of distinct ATM mutations in ataxia-telangiectasia, Am J Hum Genet, 59, 839

Castellvi-Bel, 1999, New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel strategy, Hum Mutat, 14, 156, 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E

Teraoka, 1999, Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and phenotypic consequences, Am J Hum Genet, 64, 1617, 10.1086/302418

Watters, 1997, Cellular localization of the ataxia-telangiectasia (ATM) gene product and discriminate between mutated and normal forms, Oncogene, 14, 1911, 10.1038/sj.onc.1201037

Shafman, 1997, Interaction between ATM protein and c-abl in response to DNA damage, Nature, 387, 520, 10.1038/387520a0

Smith, 1999, Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM, Proc Natl Acad Sci, 96, 11134, 10.1073/pnas.96.20.11134

Hacia, 1998, Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays, Genome Res, 8, 1245, 10.1101/gr.8.12.1245

Liu, 1999, Detection of virtually all mutations—SSCP (DOVAM-S): A rapid method for mutation scanning with virtually 100% sensitivity, BioTechniques, 26, 932, 10.2144/99265rr03